Cardiol Therapeutics Inc. (OTCMKTS:CRTPF – Get Free Report)’s share price traded up 2.8% during trading on Monday . The stock traded as high as $1.13 and last traded at $1.10. 212,462 shares were traded during trading, an increase of 217% from the average session volume of 67,097 shares. The stock had previously closed at $1.07.
Cardiol Therapeutics Stock Performance
The business’s 50-day simple moving average is $1.04 and its 200 day simple moving average is $1.25.
About Cardiol Therapeutics
Cardiol Therapeutics Inc is a clinical-stage biotechnology company that focuses on the research and clinical development of anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its product, CardiolRx, is a pharmaceutically produced extra strength oral cannabidiol formulation that is entering a Phase II/III outcomes study in hospitalized patients testing positive for the COVID-19 virus.
Featured Articles
- Five stocks we like better than Cardiol Therapeutics
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Workday Stock Price Implosion: An Automatic Buy for AI Investors
- How to Buy Gold Stock and Invest in Gold
- MercadoLibre Is Soaring—Should You Wait for a Better Entry?
- What Are the FAANG Stocks and Are They Good Investments?
- Doubt the Market? 3 Stocks to Rideout Fear, Uncertainty and Doubt
Receive News & Ratings for Cardiol Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiol Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
